Home » Sopherion Therapeutics Secures $55 Million in Series C Funding
Sopherion Therapeutics Secures $55 Million in Series C Funding
Sopherion Therapeutics, LLC, a biopharmaceutical company focused on the development and commercialization of anti-cancer therapies, has announced a $55 million Series C financing.
The Earth Times
The Earth Times
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May